Santhera’s Vamorolone For DMD Among Orphan Drugs Up For EU Marketing Decision
The European Medicines Agency is this week due to decide whether to recommend pan-EU marketing authorization for a number of new products.

The European Medicines Agency is this week due to decide whether to recommend pan-EU marketing authorization for a number of new products.